National Health Investors (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

NHI has been the subject of several other research reports. Cantor Fitzgerald upped their price target on shares of National Health Investors from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 8th. Stifel Nicolaus set a $83.00 price target on shares of National Health Investors and gave the stock a “buy” rating in a research report on Tuesday, August 7th. SunTrust Banks restated a “hold” rating and set a $79.00 price target on shares of National Health Investors in a research report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Wells Fargo & Co restated a “hold” rating on shares of National Health Investors in a research report on Tuesday, August 28th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $75.22.

NHI stock opened at $75.98 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 14.53 and a quick ratio of 15.56. National Health Investors has a 1-year low of $62.71 and a 1-year high of $81.60. The firm has a market cap of $3.18 billion, a price-to-earnings ratio of 14.26, a price-to-earnings-growth ratio of 3.23 and a beta of 0.30.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, November 6th. The real estate investment trust reported $0.97 earnings per share for the quarter, missing the consensus estimate of $1.39 by ($0.42). National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The business had revenue of $74.92 million for the quarter, compared to the consensus estimate of $73.72 million. During the same quarter in the previous year, the firm earned $1.37 EPS. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. Equities research analysts predict that National Health Investors will post 5.5 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently modified their holdings of NHI. Truvestments Capital LLC purchased a new stake in National Health Investors during the third quarter valued at about $108,000. First Hawaiian Bank purchased a new stake in National Health Investors during the third quarter valued at about $162,000. Nissay Asset Management Corp Japan ADV purchased a new stake in National Health Investors during the third quarter valued at about $203,000. Zeke Capital Advisors LLC purchased a new stake in National Health Investors during the second quarter valued at about $201,000. Finally, MML Investors Services LLC purchased a new stake in National Health Investors during the third quarter valued at about $212,000. 68.79% of the stock is owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Marijuana Stocks

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.